相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer
Agnieszka Anna Rawluszko-Wieczorek et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
Sahar Olsadat Sajadian et al.
CLINICAL EPIGENETICS (2015)
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
Santiago Uribe-Lewis et al.
GENOME BIOLOGY (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells
Bruno Di Stefano et al.
NATURE (2014)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
Tim Mueller et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
DNA methylation profiling in the clinic: applications and challenges
Holger Heyn et al.
NATURE REVIEWS GENETICS (2012)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Sarah C. Mutka et al.
CANCER RESEARCH (2009)
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Moshe Szyf
Annual Review of Pharmacology and Toxicology (2008)
分享论文
